Author Question: Which of the following is the correct order of decreasing acid strength (more acidic > less ... (Read 62 times)

colton

  • Hero Member
  • *****
  • Posts: 627
Which of the following is the correct order of decreasing acid strength (more acidic > less acidic)?
   
  a.
  FCH2COOH > CH3COOH > F2CHCOOH
   
  b.
  FCH2COOH > CH3COOH > CH3OH
   
  c.
  CH3CH2OH > ClCH2COOH > BrCH2COOH
   
  d.
  CH3COOH > ClCH2COOH > CH3OH

Question 2

Draw the structure of (Z)-4-methylhex-3-enoic acid.

Question 3

What is the IUPAC name of the following compound?
 
   


   
  a.
  5,5-dimethyl-5-phenylpentanoic acid
   
  b.
  5-methyl-5-phenylhexanoic acid
   
  c.
  2,2-dimethylphenylpropanoic acid
   
  d.
  5,5-dimethyl-5-phenylbutanal

Question 4

Which of the following does not represent a similarity between nitriles and carboxylic acids?
   
  a.
  contain 3 carbon bonds to an electronegative element
   
  b.
  contain two  bonds.
   
  c.
  act as electrophiles
   
  d.
  undergo nucleophilic substitution reactions
   
  e.
  all of these are characteristic of both nitriles and carboxylic acids.



courtney_bruh

  • Sr. Member
  • ****
  • Posts: 308
Answer to Question 1

b

Answer to Question 2



Answer to Question 3

b

Answer to Question 4




Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

For a complete list of videos, visit our video library